Biomarkers in Alzheimer's disease clinical trials: 2025
Abstract Biomarkers play an important role in Alzheimer's disease (AD) clinical trials in several contexts of use, including defining trial eligibility and serving as outcome measures. Utilizing clinicaltrials.gov, a registry of clinical trials, we assessed biomarker usage across all active AD disea...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wiley
2026-01-01
|
| Sarja: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Aiheet: | |
| Linkit: | https://doi.org/10.1002/trc2.70217 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|